SOURCE: Daxor Corp.

March 14, 2007 08:30 ET

Daxor Announces Prince George's Hospital Center of Cheverly, MD Acquires BVA-100 Blood Volume Analyzer

NEW YORK, NY -- (MARKET WIRE) -- March 14, 2007 -- Daxor Corporation (AMEX: DXR), a medical instrumentation and biotechnology company, today announced the receipt of a signed trial agreement from Prince George's Hospital Center of Cheverly, Maryland.

Prince George's Hospital Center was founded in 1944 and is a 290-bed acute care teaching hospital and regional referral center. It is a member of the Dimensions Healthcare System, the largest not-for-profit provider of healthcare services in Prince George's County.

As one of the largest employers in Prince George's County, Prince George's Hospital Center provides a comprehensive range of inpatient and outpatient medical and surgical services including: the designated regional trauma center for southern Maryland; a comprehensive cardiac care program unique to Prince George's county; open-heart surgery and therapeutic catheterization; level III neonatal intensive care and perinatal diagnostic center; comprehensive outpatient services; and an intensive services pavilion housing 10 operating suites, 24-bed intensive care unit, catheterization labs and endoscopy suites.

Daxor's Blood Volume Analyzer BVA-100 will be located within Prince George's Hospital Center's Nuclear Medicine Department, and will be utilized to diagnose a variety of patient blood volume derangements.

Other nationally renowned hospitals which have purchased the BVA-100 Blood Volume Analyzer after using it on a clinical trial basis are The Mayo Clinic, The Cleveland Clinic, and New York University Medical Center. Daxor Corporation manufactures and markets the BVA-100, a semi-automated Blood Volume Analyzer. The BVA-100 is used in conjunction with Volumex, Daxor's single use diagnostic kit. For more information regarding Daxor Corporation's Blood Volume Analyzer BVA-100, visit Daxor's website www.Daxor.com.

Contact Information

  • Contact Information:

    Stephen Feldschuh
    Chief Operating Officer
    212-330-8515
    Email Contact

    Diane Meegan
    Investor Relations
    212-330-8512
    Email Contact